Keros Therapeutics DSO Ratio 2011-2026 | KROS

Annual DSO Ratio Keros Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.72	148	-	-	163	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
163	4.72	105

Quarterly DSO Ratio Keros Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
62.4	83.1	4.33	-	46.1	284	203	-	-	-	-	-	-	-	-	-	-	45.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
284	4.33	104

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Benitec Biopharma BNTC	141	$ 10.98	-4.52 %	$ 452 M	USA
Ascendis Pharma A/S ASND	132	$ 221.88	-0.87 %	$ 5 B	Danmark
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Assembly Biosciences ASMB	25.1	$ 28.46	3.45 %	$ 319 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Axsome Therapeutics AXSM	105	$ 156.92	-1.23 %	$ 7.81 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	173	$ 3.4	-3.68 %	$ 1.02 B	Canada
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
BioMarin Pharmaceutical BMRN	88.9	$ 54.13	-1.64 %	$ 10.4 B	USA
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Compugen Ltd. CGEN	60.8	$ 2.09	-0.95 %	$ 195 M	Israel
Coherus BioSciences CHRS	559	$ 1.52	-5.59 %	$ 178 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.6	-3.8 %	$ 115 M	USA
Curis CRIS	103	$ 0.77	1.89 %	$ 4.86 M	USA